Balinsua, April Rose Y.
HRN: 27-68-00 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2025
CEFTRIAXONE 1G (VIAL)
08/31/2025
09/07/2025
IV
2gms
OD X 7 Days
T/C Endometritis
Checking Initial Appropriateness
09/01/2025
AMPICILLIN 1GM (VIAL)
09/01/2025
09/08/2025
IV
2g
Q6h
T/C Endometritis
Checking Initial Appropriateness
09/04/2025
METRONIDAZOLE 500MG (TAB)
09/04/2025
09/11/2025
PO
1 Tab
TID
S/P D&C
Checking Initial Appropriateness
09/04/2025
CO-AMOXICLAV 625MG (TAB)
09/04/2025
09/11/2025
PO
1 Tab
TID
S/P CS
Checking Initial Appropriateness